PT862643E - Funcoes acessorias para utilizacao na producao de virioes de aav recombinantes - Google Patents
Funcoes acessorias para utilizacao na producao de virioes de aav recombinantesInfo
- Publication number
- PT862643E PT862643E PT96940378T PT96940378T PT862643E PT 862643 E PT862643 E PT 862643E PT 96940378 T PT96940378 T PT 96940378T PT 96940378 T PT96940378 T PT 96940378T PT 862643 E PT862643 E PT 862643E
- Authority
- PT
- Portugal
- Prior art keywords
- aav
- production
- helper virus
- adenoviral
- facts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10351—Methods of production or purification of viral material
- C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10361—Methods of inactivation or attenuation
- C12N2710/10362—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US640295P | 1995-11-09 | 1995-11-09 | |
US08/745,957 US6004797A (en) | 1995-11-09 | 1996-11-07 | Adenovirus helper-free recombinant AAV Virion production |
Publications (1)
Publication Number | Publication Date |
---|---|
PT862643E true PT862643E (pt) | 2005-01-31 |
Family
ID=26675580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96940378T PT862643E (pt) | 1995-11-09 | 1996-11-08 | Funcoes acessorias para utilizacao na producao de virioes de aav recombinantes |
Country Status (9)
Country | Link |
---|---|
US (4) | US6004797A (pt) |
EP (2) | EP1522588A3 (pt) |
JP (2) | JP4473346B2 (pt) |
AT (1) | ATE278789T1 (pt) |
CA (1) | CA2236968C (pt) |
DE (1) | DE69633572T2 (pt) |
ES (1) | ES2230569T3 (pt) |
PT (1) | PT862643E (pt) |
WO (1) | WO1997017458A1 (pt) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6040183A (en) * | 1995-06-07 | 2000-03-21 | University Of North Carloina At Chapel Hill | Helper virus-free AAV production |
US6093570A (en) * | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
US6001650A (en) * | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
US6027931A (en) * | 1995-08-03 | 2000-02-22 | Avigen, Inc. | High-efficiency AA V helper functions |
CA2230758A1 (en) | 1995-09-08 | 1997-03-13 | Genzyme Corporation | Improved aav vectors for gene therapy |
US6004797A (en) * | 1995-11-09 | 1999-12-21 | Avigen, Inc. | Adenovirus helper-free recombinant AAV Virion production |
JP2006075171A (ja) * | 1995-11-09 | 2006-03-23 | Avigen Inc | 組換えaavビリオン産生における使用のための補助機能 |
US20020037867A1 (en) * | 1999-02-26 | 2002-03-28 | James M. Wilson | Method for recombinant adeno-associated virus-directed gene therapy |
DE19644500C2 (de) * | 1996-10-25 | 1998-11-05 | Deutsches Krebsforsch | AAV-DNA mit Helfervirus-Sequenzen |
US6221646B1 (en) | 1997-07-31 | 2001-04-24 | Chiron Corporation | Materials and methods for simplified AAV production |
US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
DK1944362T3 (en) | 1997-09-05 | 2016-01-25 | Genzyme Corp | Fremgangsmåder til fremstilling af hjælpevirusfri præparater med høj titer af rekombinante AAV-vektorer |
US6989264B2 (en) | 1997-09-05 | 2006-01-24 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
US6953690B1 (en) | 1998-03-20 | 2005-10-11 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
CA2324225A1 (en) * | 1998-03-20 | 1999-09-23 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
US6291214B1 (en) * | 1998-05-11 | 2001-09-18 | Glaxo Wellcome Inc. | System for generating recombinant viruses |
ES2324540T3 (es) | 1998-05-27 | 2009-08-10 | Genzyme Corporation | Vectores aav para la fabricacion de medicamentos para la administracion potenciada por conveccion. |
WO1999067400A1 (en) | 1998-06-24 | 1999-12-29 | Musc Foundation For Research Development | Tissue-specific and target rna-specific ribozymes |
EP2942393A1 (en) | 1998-09-04 | 2015-11-11 | Genzyme Corporation | Methods for generating high titer helper-free preparations of released recombinant aav vectors |
WO2000022152A1 (en) * | 1998-10-13 | 2000-04-20 | Avigen, Inc. | Compositions and methods for producing recombinant adeno-associated virus |
JP2002528087A (ja) * | 1998-10-27 | 2002-09-03 | クルセル ホランド ベー ヴェー | 改良aavベクター産生 |
US6509150B1 (en) * | 1999-03-05 | 2003-01-21 | Universite De Nantes | Compositions and methods for recombinant Adeno-Associated Virus production |
JP4693244B2 (ja) | 1999-03-18 | 2011-06-01 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法 |
US6258595B1 (en) * | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
US6271359B1 (en) | 1999-04-14 | 2001-08-07 | Musc Foundation For Research Development | Tissue-specific and pathogen-specific toxic agents and ribozymes |
DK1180159T3 (da) | 1999-05-28 | 2008-11-17 | Targeted Genetics Corp | Fremgangsmåder og sammensætninger til at sænke niveauet af Tumor-Nekrose-Faktor (TNF) i TNF-associerede lidelser |
EP1939300A1 (en) | 1999-05-28 | 2008-07-02 | Targeted Genetics Corporation | Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
ES2308989T3 (es) | 1999-08-09 | 2008-12-16 | Targeted Genetics Corporation | Aumento de la expresion de una secuencia nucleotidica heterologa a partir de vectores viricos recombinantes que contienen una secuencia que forman pares de bases intracatenarios. |
EP1916258B1 (en) | 1999-08-09 | 2014-04-23 | Targeted Genetics Corporation | Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
AU1775901A (en) * | 1999-11-17 | 2001-05-30 | Avigen, Inc. | Recombinant adeno-associated virus virions for the treatment of lysosomal disorders |
AU3274401A (en) * | 2000-01-05 | 2001-07-16 | Fred Hutchinson Cancer Research Center | Compositions and methods for efficient aav vector production |
EP1702983A3 (en) | 2000-04-13 | 2007-01-10 | Medical University of South Carolina | Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof |
ES2288993T3 (es) * | 2000-08-17 | 2008-02-01 | Keiya Ozawa | Distribucion de factores angiogenicos mediada por virus adenoasociados. |
DE10056210A1 (de) * | 2000-11-13 | 2002-05-29 | Arimedes Biotechnology Gmbh | Virales Expressionssystem |
WO2003086451A1 (en) * | 2002-04-05 | 2003-10-23 | Centocor, Inc. | Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses |
ATE490307T1 (de) | 2003-05-21 | 2010-12-15 | Genzyme Corp | Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind |
SI2657248T1 (sl) | 2003-06-19 | 2017-07-31 | Genzyme Corporation | AAV virioni z zmanjšano imunoreaktivnostjo in njihova uporaba |
US7261882B2 (en) | 2003-06-23 | 2007-08-28 | Reagents Of The University Of Colorado | Methods for treating neuropathic pain by administering IL-10 polypeptides |
EP1648520B1 (en) * | 2003-07-16 | 2010-05-05 | RVX Therapeutics, Inc. | Compounds and methods for downregulating the effects of tgf-beta |
US7427396B2 (en) * | 2004-06-03 | 2008-09-23 | Genzyme Corporation | AAV vectors for gene delivery to the lung |
AU2005287393A1 (en) * | 2004-06-18 | 2006-03-30 | The University Of Montana | AAV mediated gene delivery to cochlear cells |
MX2007003850A (es) | 2004-10-05 | 2007-11-21 | Genzyme Corp | Canula escalonada. |
US7943374B2 (en) * | 2005-08-21 | 2011-05-17 | Markus Hildinger | Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb |
TR201906398T4 (tr) | 2009-04-30 | 2019-05-21 | Univ Pennsylvania | Salgı bezleriyle ilişkili virüs yapılarını içeren iletken hava yolu hücrelerinin hedeflenmesine yönelik bileşimler. |
CA2759801C (en) | 2009-05-02 | 2019-04-02 | Marco A. Passini | Gene therapy for neurodegenerative disorders |
AU2011209743B2 (en) | 2010-01-28 | 2016-03-10 | The Children's Hospital Of Philadelphia | A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
ES2461147T3 (es) | 2010-03-26 | 2014-05-16 | Deutsches Krebsforschungszentrum | Virus cooperador obtenido a partir de adenovirus para mejorar la producción de parvovirus recombinantes |
EP2670426B1 (en) | 2011-01-31 | 2017-05-10 | The General Hospital Corporation | Multimodal trail molecules and uses in cellular therapies |
US20150004144A1 (en) | 2011-12-02 | 2015-01-01 | The General Hospital Corporation | Differentiation into brown adipocytes |
EP2871239B1 (en) | 2012-07-06 | 2018-08-29 | Takara Bio Inc. | Cell capable of producing adeno-associated virus vector |
US9605074B2 (en) | 2012-08-30 | 2017-03-28 | The General Hospital Corporation | Multifunctional nanobodies for treating cancer |
SG10201708547YA (en) | 2013-04-17 | 2017-11-29 | Genzyme Corp | Compositions and methods for treating and preventing macular degeneration |
CA2913155A1 (en) | 2013-05-21 | 2014-11-27 | President And Fellows Of Harvard College | Engineered heme-binding compositions and uses thereof |
CN105339495A (zh) | 2013-07-11 | 2016-02-17 | 宝生物工程株式会社 | 制备无包膜病毒的方法 |
WO2015031686A1 (en) | 2013-08-30 | 2015-03-05 | Amgen Inc. | High titer recombinant aav vector production in adherent and suspension cells |
MX2016010215A (es) | 2014-02-06 | 2016-11-15 | Genzyme Corp | Composiciones y metodos de tratamiento y prevencion de degeneracion macular. |
WO2016006658A1 (ja) | 2014-07-10 | 2016-01-14 | タカラバイオ株式会社 | 非エンベロープウイルス粒子の製造方法 |
WO2016044707A1 (en) | 2014-09-18 | 2016-03-24 | Cedars-Sinai Medical Center | Compositions and methods for treating fibrosis |
CN107109374B (zh) | 2015-01-09 | 2021-04-06 | 宝生物工程株式会社 | 用于生产无包膜病毒颗粒的方法 |
WO2016168601A1 (en) | 2015-04-17 | 2016-10-20 | Khalid Shah | Agents, systems and methods for treating cancer |
EP4194001A1 (en) | 2015-04-22 | 2023-06-14 | Cedars-Sinai Medical Center | Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes and obesity |
HUE061100T2 (hu) | 2016-03-28 | 2023-05-28 | Ultragenyx Pharmaceutical Inc | Adenovírus hõinaktiválásának módszerei |
BR112018070256A2 (pt) | 2016-03-31 | 2019-01-29 | Spark Therapeutics Inc | processo de fabricação de raav totalmente escalável à base de colunas |
EP3526321A4 (en) | 2016-10-14 | 2020-05-13 | Ultragenyx Pharmaceutical Inc. | USE OF TONIFYING AGENTS TO IMPROVE THE YIELD OF RECOMBINANT ADENO-ASSOCIATED VIRUS |
JP7142643B2 (ja) | 2017-03-22 | 2022-09-27 | ウルトラジェニックス ファーマシューティカル インコーポレイテッド | Hdac阻害剤またはrepタンパク質を伴う細胞培養方法 |
AU2018281306A1 (en) | 2017-06-07 | 2020-01-16 | Spark Therapeutics, Inc. | Enhancing agents for improved cell transfection and/or rAAV vector production |
US11414785B2 (en) | 2019-08-13 | 2022-08-16 | Waters Technologies Corporation | Affinity resins and sample preparation devices based on cartilaginous fish IgNAR derived binding domains |
US20230013253A1 (en) | 2019-12-19 | 2023-01-19 | Pfizer Inc. | Compostions and methods for nucleic acid transfection using cationic polymers and stabilizers |
IL295129A (en) | 2020-01-30 | 2022-09-01 | Umoja Biopharma Inc | Bispecific transduction enhancer |
WO2021236908A2 (en) | 2020-05-20 | 2021-11-25 | Biomarin Pharmaceutical Inc. | Use of regulatory proteins for the production of adeno-associated virus |
KR20230043869A (ko) | 2020-08-07 | 2023-03-31 | 스페이스크래프트 세븐, 엘엘씨 | Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법 |
IL302046A (en) | 2020-10-15 | 2023-06-01 | Hoffmann La Roche | Nucleic acid structures for va RNA transcription |
US20220154223A1 (en) | 2020-10-15 | 2022-05-19 | Hoffmann-La Roche Inc. | Nucleic acid constructs for simultaneous gene activation |
JP2023548067A (ja) | 2020-11-02 | 2023-11-15 | バイオマリン ファーマシューティカル インコーポレイテッド | アデノ随伴ウイルスを濃縮するためのプロセス |
WO2023060113A1 (en) * | 2021-10-05 | 2023-04-13 | Regenxbio Inc. | Compositions and methods for recombinant aav production |
CN118202060A (zh) * | 2021-10-05 | 2024-06-14 | 再生生物股份有限公司 | 用于重组aav生产的组合物和方法 |
WO2023198685A1 (en) | 2022-04-13 | 2023-10-19 | F. Hoffmann-La Roche Ag | Method for determining aav genomes |
WO2023227438A1 (en) | 2022-05-23 | 2023-11-30 | F. Hoffmann-La Roche Ag | Raman-based method for the differentiation of aav particle serotype and aav particle loading status |
WO2023232922A1 (en) | 2022-06-03 | 2023-12-07 | F. Hoffmann-La Roche Ag | Method for producing recombinant aav particles |
WO2024013239A1 (en) | 2022-07-14 | 2024-01-18 | F. Hoffmann-La Roche Ag | Method for producing recombinant aav particles |
WO2024056561A1 (en) | 2022-09-12 | 2024-03-21 | F. Hoffmann-La Roche Ag | Method for separating full and empty aav particles |
WO2024064863A2 (en) | 2022-09-22 | 2024-03-28 | Biomarin Pharmaceutical Inc. | Treatment of arrhythmogenic cardiomyopathy with aav gene therapy vectors |
WO2024064856A1 (en) | 2022-09-22 | 2024-03-28 | Biomarin Pharmaceutical Inc. | Treatment of cardiomyopathy with aav gene therapy vectors |
WO2024165456A1 (en) | 2023-02-07 | 2024-08-15 | F. Hoffmann-La Roche Ag | Method for the detection of anti-aav particle antibodies |
WO2024194280A1 (en) | 2023-03-21 | 2024-09-26 | F. Hoffmann-La Roche Ag | Method for the production of recombinant aav particle preparations |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5436146A (en) * | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
US5173414A (en) * | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
US6268213B1 (en) * | 1992-06-03 | 2001-07-31 | Richard Jude Samulski | Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy |
FR2705686B1 (fr) * | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
RU2219241C2 (ru) * | 1993-07-13 | 2003-12-20 | Рон-Пуленк Роре С.А. | Дефектный рекомбинантный аденовирусный вектор (варианты) |
FR2707664B1 (fr) * | 1993-07-13 | 1995-09-29 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
ES2220923T3 (es) * | 1993-11-09 | 2004-12-16 | Medical College Of Ohio | Lineas celulares estables capaces de expresar el gen de replicacion del virus adeno-asociado. |
US5872005A (en) * | 1994-11-03 | 1999-02-16 | Cell Genesys Inc. | Packaging cell lines for adeno-associated viral vectors |
IL116816A (en) * | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
US6281010B1 (en) * | 1995-06-05 | 2001-08-28 | The Trustees Of The University Of Pennsylvania | Adenovirus gene therapy vehicle and cell line |
AU707862B2 (en) * | 1995-06-07 | 1999-07-22 | University Of North Carolina At Chapel Hill, The | Helper virus-free aav production |
CA2230758A1 (en) * | 1995-09-08 | 1997-03-13 | Genzyme Corporation | Improved aav vectors for gene therapy |
US6004797A (en) * | 1995-11-09 | 1999-12-21 | Avigen, Inc. | Adenovirus helper-free recombinant AAV Virion production |
US5945335A (en) * | 1995-11-09 | 1999-08-31 | Avigen, Inc. | Adenovirus helper-free system for producing recombinant AAV virions lacking oncogenic sequences |
-
1996
- 1996-11-07 US US08/745,957 patent/US6004797A/en not_active Expired - Lifetime
- 1996-11-08 CA CA002236968A patent/CA2236968C/en not_active Expired - Lifetime
- 1996-11-08 EP EP04022844A patent/EP1522588A3/en not_active Withdrawn
- 1996-11-08 JP JP51838297A patent/JP4473346B2/ja not_active Expired - Lifetime
- 1996-11-08 ES ES96940378T patent/ES2230569T3/es not_active Expired - Lifetime
- 1996-11-08 PT PT96940378T patent/PT862643E/pt unknown
- 1996-11-08 WO PCT/US1996/018089 patent/WO1997017458A1/en active IP Right Grant
- 1996-11-08 AT AT96940378T patent/ATE278789T1/de not_active IP Right Cessation
- 1996-11-08 EP EP96940378A patent/EP0862643B1/en not_active Expired - Lifetime
- 1996-11-08 DE DE69633572T patent/DE69633572T2/de not_active Expired - Lifetime
-
1999
- 1999-09-28 US US09/406,363 patent/US6482633B1/en not_active Expired - Lifetime
-
2002
- 2002-06-19 US US10/177,871 patent/US6897063B2/en not_active Expired - Lifetime
-
2005
- 2005-01-26 US US11/043,312 patent/US7485458B2/en not_active Expired - Fee Related
-
2011
- 2011-10-06 JP JP2011222072A patent/JP2012050453A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0862643B1 (en) | 2004-10-06 |
US6004797A (en) | 1999-12-21 |
DE69633572T2 (de) | 2005-10-06 |
EP0862643A1 (en) | 1998-09-09 |
US20030170896A1 (en) | 2003-09-11 |
EP1522588A3 (en) | 2006-06-07 |
US6897063B2 (en) | 2005-05-24 |
JP2012050453A (ja) | 2012-03-15 |
US6482633B1 (en) | 2002-11-19 |
JP2001517071A (ja) | 2001-10-02 |
CA2236968A1 (en) | 1997-05-15 |
ATE278789T1 (de) | 2004-10-15 |
CA2236968C (en) | 2007-05-08 |
DE69633572D1 (de) | 2004-11-11 |
US20050164392A1 (en) | 2005-07-28 |
ES2230569T3 (es) | 2005-05-01 |
WO1997017458A1 (en) | 1997-05-15 |
US7485458B2 (en) | 2009-02-03 |
EP1522588A2 (en) | 2005-04-13 |
JP4473346B2 (ja) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT862643E (pt) | Funcoes acessorias para utilizacao na producao de virioes de aav recombinantes | |
ATE348182T1 (de) | Rekombinantes adeno-assoziiertes virus | |
ATE550429T1 (de) | Adenovirus-zusammensetzungen erhältlich durch ein verbessertes produktions- und reinigungsverfahren | |
NZ336829A (en) | Adenoviruses having altered hexon proteins which present epitopes that are not recognised by neutralizing antibodies to the unmodified adenovirus of another serotype | |
CY1113731T1 (el) | Μεθοδοι για δημιουργια παρασκευασματων κομιστων ανασυνδυασμενου aav υψηλου τιτλου απαλλαγμενων απο βοηθητικο ιο | |
MX9603002A (es) | Procedimiento para la preparacion de virus asociados a los adenovirus (aav), recombinantes, y usos de los mismos. | |
BR9710030A (pt) | Processo de produção de adenovírus recombinantes processo de purificação de adenovírus recombinantes a partir de um meio biológico preparação viral purificada composição farmacêutica e utilização de iodixanol-5,5'-[(2-Hidroxipropil-1,3-Propanottl)-Bis[N,N'-Bis(2,3-Didroxipropil-2,4,6-Triodo-1,3-Benzenocarboxamida] | |
CA2230655A1 (en) | Chromatographic purification of adenovirus and aav | |
AU1958092A (en) | Recombinant fowlpox virus | |
DE69939169D1 (de) | Aav5 vektoren und deren verwendung | |
FI931109A (fi) | Peptider och nukleinsyrasekvenser, som haenfoer sig till epstein-barr-virus | |
ES2164910T3 (es) | Virus auxiliares para la preparacion de vectores virales recombinantes. | |
DE69721840D1 (en) | Zuckerrohr bacilliformviruspromotor | |
IL77694A (en) | Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging | |
JP2002537816A5 (pt) | ||
FR2445338A1 (fr) | Preparation de glycoproteine isolee d'enveloppes d'onco-rna virus et vaccins qui la contiennent | |
IT8420220A0 (it) | Tipo eteropoliacido contenente composizione di catalizzatore del baffi "whiskers". | |
ATE103328T1 (de) | Fuer ein glykoprotein des aids-virus kodierende virus-vektoren, vakzin und antikoerper. | |
DE69629322D1 (de) | Fester Ceriumoxid Elektrolyt mit Struktur des Fluorittypes | |
CA2187162A1 (en) | Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) | |
DK498387A (da) | Virus-dna-sekvens | |
ATE286507T1 (de) | Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen | |
CA2187161A1 (en) | Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) | |
KR920009981A (ko) | 아데노-관련된 바이러스 타입 2에 의해 암호화되는 rep 유전자의 항바이러스 활성 | |
Tijssen et al. | Studies on the structure of the two infectious types of densonucleosis virus |